Simpson Thacher represented BNP PARIBAS, BofA Securities, Goldman Sachs, HSBC, MUFG, Barclays, Citigroup, Deutsche Bank Securities, ING, J.P. Morgan, Mizuho Securities, Morgan Stanley, RBC Capital Markets,...
Equinix’s $1.2 Billion Senior Notes Offering
Workday’s $3 Billion Senior Notes Offering
Davis Polk advised the joint book-running managers in the offering while Fenwick represented Workday. Workday, Inc. executed an $3 billion SEC-registered debt offering. The offering consisted of $1...
Weyerhaeuser’s $900 Million Notes Offering and Cash Tender Offer
Cravath represented Weyerhaeuser Company, while Davis Polk advised the joint book-running managers and the lead dealer managers in the transaction. Weyerhaeuser Company executed its SEC-registered offering...
Denali Therapeutics’ $400 Million At-The-Market Offering
Davis Polk advised the sales agents in the transaction. The transaction consists in a new SEC-registered at-the-market offering program by Denali Therapeutics Inc. under which Denali...
Credo Technology Group’s $200 Million Initial Public Offering
Davis Polk advised Credo Technology Group Holding Ltd on the IPO while S&C represented the underwriters. Credo announced its $200 million initial public offering of 20,000,000 ordinary...
Senti Biosciences’ Business Combination with Dynamics Special Purpose Corp.
Goodwin Procter advised Senti Biosciences, while Davis Polk advised Dynamics Special Purpose Corp. on the deal. Senti Biosciences (“Senti Bio”) announced its definitive business combination agreement with...
Marathon Digital Holdings’ $650 Million Convertible Senior Notes Offering
Davis Polk advised Marathon Digital, while Latham & Watkins represented the initial purchasers in the offering. Marathon Digital Holdings, Inc., one of the largest enterprise Bitcoin...
Cryoport’s $403 Million Notes Offering
Davis Polk advised the initial purchasers in the offering. Latham & Watkins represented Cryoport in the offering. Cryoport, Inc. executed the offering of $402.5 million aggregate...
Revolution Medicines’ $250 Million Shares Offering
Davis Polk advised the sales agent, Cowen, in the offering. Revolution Medicines, Inc. announced it may issue and sell shares of its common stock for up...
SiTime’s $518 Million Shares Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in the offering. SiTime Corporation executed its offering of 2,300,000 shares of common stock,...
Cryoport’s $249 Million Stock Offering
Davis Polk advised the placement agents in the offering. Cryoport executed its direct offering of 3,072,038 shares of its common stock, for total gross proceeds of approximately $249.1...
First Advantage’s $345 Million Shares Offering
Simpson Thacher represented First Advantage, while Davis Polk advised the representatives of the several underwriters in the offering. First Advantage announced the $345 million secondary offering of...